Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants 05 February
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline 03 February
